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782 Combined administration of nitric oxide gas and iloprost during
cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study
Ada Chung, PhD, Stephen M. Wildhirt, MD, PhD, Shoa Wang, MD, Arvind Koshal, MD, and
Marek W. Radomski, MD, PhD, DSc, Edmonton, Alberta, Canada; Munich, Germany; and
Houston, Tex
NO and iloprost were used to reduce platelet-leukocyte dysfunction and postoperative bleeding
in patients subjected to CPB. CPB induced activation of platelets and formation of platelet-
leukocyte aggregates. The combined therapy was most useful in preventing thrombocytopenia
and loss of aggregative function. Both NO and combined therapy reduced postoperative blood
loss.
791 Alterations in transmural strains adjacent to ischemic myocardium during
acute midcircumflex occlusion [VIDEO]
Filiberto Rodriguez, MD, Frank Langer, MD, Katherine B. Harrington, BA, Allen Cheng, MD,
George T. Daughters, MS, John C. Criscione, MD, PhD, Neil B. Ingels, PhD, and
D. Craig Miller, MD, Stanford and Palo Alto, Calif, and College Station, Tex
The complex cardiac microstructure, consisting of helically oriented fibers forming transmural
myolaminar sheets, is essential for LV wall-thickening mechanics. We quantified transmural
3-D myocardial strains adjacent to ischemic myocardium during acute midcircumflex occlusion
and identified abrupt strain alterations, which might trigger progression into global ischemic
cardiomyopathy.
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804 Surgical resection for lung cancer with infiltration of the thoracic aorta Œ
Mitsunori Ohta, MD, Hirohisa Hirabayasi, MD, Hiroyuki Shiono, MD, Masato Minami, MD,
Hajime Maeda, MD, Hiroshi Takano, MD, Shinichiro Miyoshi, MD, and Hikaru Matsuda, MD,
Osaka and Tochigi, Japan
We retrospectively evaluated 16 patients who underwent a combined resection of the thoracic
aorta and primary lung cancer. Favorable long-term survival was obtained in patients with N0
disease, indicating that radical resection is a valid intervention in such cases.
809 Long-term graft patency after replacement of the brachiocephalic veins
combined with resection of mediastinal tumors
Yasushi Shintani, MD, Mitsunori Ohta, MD, Masato Minami, MD, Hiroyuki Shiono, MD,
Hirohisa Hirabayashi, MD, Masayoshi Inoue, MD, Goro Matsumiya, MD, and Hikaru
Matsuda, MD, Osaka, Japan
We report long-term graft patency after replacement of the brachiocephalic veins (BCVs)
combined with resection of mediastinal tumors. Right BCV or bilateral separate BCV
reconstruction should be considered for SVC replacement.
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